Week39, 2022
1. Influenza activity remains low, with 1.0% of clinical specimens and 3.95% of public health specimens testing positive for influenza.
2. Clinical labs reported 64.0% of positive specimens as Influenza A and 36.0% as Influenza B.
3. Public health labs detected 84.2% Influenza A, primarily (H1N1)pdm09 (95.2%), with 15.8% Influenza B categorized under the Victoria lineage.
4. Outpatient visits for ILI accounted for 2.1% of consultations, with the highest rates among children aged 0-4 years (7.1%) and those aged 5-24 years (3.3%).
5. Hospitalizations included 1,040 patients with laboratory-confirmed influenza during Week 39.
6. Deaths attributed to pneumonia, influenza, and/or COVID-19 (PIC) were 7.3% of all reported deaths, surpassing the epidemic threshold of 5.7%; 11 deaths were attributed to influenza.
7. One pediatric influenza-associated death was reported for the 2022-2023 season as of Week 39.
8. Various respiratory viruses, including SARS-CoV-2 and RSV, are co-circulating and contributing to ILI visits across the U.S.
9. Flu activity remains minimal in 44 jurisdictions, with only a few areas reporting moderate or higher activity.
10. The CDC recommends vaccination, though no updates on vaccination trends were included in this report. Future predictions remain uncertain due to the variability of co-circulating viruses.